Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

Hypertension I: Introduction

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

Hypertension V: Nursing Management

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fatal Platypnea-Orthodeoxia Syndrome After Transcatheter Tricuspid Valve Replacement: When HALT Reverses the Shunt.

JACC. Case reports·2026

Same author

A single-centre prospective evaluation of left bundle branch area pacemaker implantation characteristics.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2022

Same author

Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases.

Journal of atrial fibrillation·2021

Same author

Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fibrillation.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021

Same author

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2019

Same author

Presence and extent of cardiac computed tomography angiography defined coronary artery disease in patients presenting with syncope.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2017

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

Semi-final masked hypertension.

B Weijs¹, M W Smulders, B S N Alzand

¹Department of Cardiology, CARIM, Maastricht University Medical Center, the Netherlands. b.weijs@mumc.nl

The Netherlands Journal of Medicine

|November 13, 2010

Summary

Masked hypertension, normal in-clinic blood pressure (BP) but high during ambulatory monitoring, indicates elevated cardiovascular risk. A clear consensus definition for this condition is still lacking.

Area of Science:

Cardiology
Hypertension Research
Clinical Medicine

Background:

Masked hypertension is characterized by normal blood pressure (BP) readings in a clinical setting but elevated BP during ambulatory monitoring.
This condition is associated with increased cardiovascular risk, similar to sustained hypertension.
Despite the recognized risks, a universally accepted definition for masked hypertension remains elusive.

Observation:

Patients with masked hypertension exhibit normal BP during routine medical visits.
Ambulatory BP monitoring reveals significantly higher BP levels in these individuals.
This discrepancy highlights the limitations of standard clinical BP measurements for diagnosing all forms of hypertension.

Findings:

The abstract identifies masked hypertension as a clinical entity with normal office BP and elevated out-of-office BP.

Related Experiment Videos

Last Updated: Jun 6, 2026

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

It underscores the heightened cardiovascular risk associated with this condition.

A key finding is the absence of a clear, consensus-based definition for masked hypertension in current medical literature.

Implications:

The lack of a standardized definition complicates diagnosis and management strategies for masked hypertension.
Further research is needed to establish clear diagnostic criteria.
Developing a consensus definition is crucial for accurate risk stratification and timely intervention in patients with masked hypertension.